2012
DOI: 10.1016/j.brainresbull.2012.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Sub-chronic treatment with pioglitazone exerts anti-convulsant effects in pentylenetetrazole-induced seizures of mice: The role of nitric oxide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
13
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 52 publications
4
13
0
Order By: Relevance
“…A chronic administration of NOS inhibitors or a NO substrate alone did not affect the epileptiform activity, which is a finding that is similar to that produced by other scholars [16].…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…A chronic administration of NOS inhibitors or a NO substrate alone did not affect the epileptiform activity, which is a finding that is similar to that produced by other scholars [16].…”
Section: Discussionsupporting
confidence: 88%
“…In fact, some researchers have suggested that NO is an endogenous anti-convulsant [16], whereas other authors have suggested a pro-convulsant role for NO [17]. Nevertheless, a comprehensive understanding of the role of NO might aid in the development of effective anti-epileptic treatments [19].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Antiepileptic efficacy of pioglitazone was reported for the first time by Okada et al [17] in genetically epileptic EL male mice. After that, the anti-convulsant effect of acute and chronic pioglitazone treatment has been revealed in several pentylenetetrazole models in male mice [18][19][20].…”
Section: Introductionmentioning
confidence: 98%
“…The recognized isoforms of NOS are: inducible (iNOS), neuronal (nNOS) and endothelial (eNOS), the last two enzymes are constitutively expressed (Förstermann and Sessa, 2012;Shafaroodi et al, 2012Shafaroodi et al, , 2015. Based upon the previous reports NO and cGMP (cyclic guanosine monophosphate) systems mediate 5 opioid antinociception and tolerace/dependence phenomena (Babey et al, 1994;Elliott et al, 1994;Vaupel et al, 1995).…”
Section: Introductionmentioning
confidence: 99%